SGRY

Surgery Partners, Inc.
$13.40
+0.12 (+0.87%)
Mkt Cap 1.75B
Volume 840,460
52W Range 11.41-24.1
Sector Healthcare
Beta 1.99
EPS (TTM) -0.59
P/E Ratio -25.23
Revenue (TTM) 3.34B
Rev Growth (5Y) +12.2%
EPS Growth (5Y) N/A

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 3.31B 3.11B 2.74B 2.54B 2.23B 1.86B 1.83B 1.77B 1.34B 1.15B 959.89M 403.29M
Net Income (77.90M) (168.10M) (11.90M) (54.60M) (70.90M) (116.10M) (74.80M) (205.71M) (52.98M) 9.45M 1.43M (65.90M)
EPS -0.61 -1.33 -0.09 -0.59 -1.12 -3.19 0.95 -4.28 -1.09 0.20 0.04 -1.37
Free Cash Flow 195.60M 209.70M 205.00M 78.20M 29.50M 204.00M 55.90M 104.80M 91.34M 86.13M N/A N/A
FCF / Share 1.54 1.66 1.63 0.85 0.41 4.18 1.16 2.18 1.88 1.79 N/A N/A
Operating CF 274.30M 300.10M 293.80M 158.80M 87.10M 246.90M 129.50M 144.60M 120.94M 125.24M N/A N/A
Total Assets 8.24B 7.89B 6.88B 6.68B 6.12B 5.41B 5.02B 4.68B 4.62B 2.30B N/A N/A
Total Debt 4.02B 3.70B 3.06B 2.93B 3.29B 3.20B 2.90B 2.48B 2.19B 1.50B N/A N/A
Cash & Equiv 239.90M 269.50M 195.90M 282.90M 389.90M 317.90M 92.70M 184.31M 174.91M 69.70M N/A N/A
Book Value 1.71B 1.79B 1.99B 2.00B 1.09B 550.10M 691.80M 404.64M 654.73M 9.68M N/A N/A
Return on Equity -0.05 -0.09 -0.01 -0.03 -0.07 -0.21 -0.11 -0.51 -0.08 0.98 N/A N/A
SGRY News
Surgery Partners, Inc. (SGRY) Q1 2026 Earnings Call Transcript
May 05, 2026 11:41 AM · seekingalpha.com
Surgery Partners (SGRY) Reports Q1 Loss, Tops Revenue Estimates
May 05, 2026 06:15 AM · zacks.com
Surgery Partners, Inc. Announces First Quarter 2026 Results Reaffirms Full Year 2026 Guidance
May 05, 2026 03:30 AM · globenewswire.com
Surgery Partners, Inc. Announces First Quarter 2026 Results Reaffirms Full Year 2026 Guidance
May 05, 2026 03:30 AM · globenewswire.com
AUNA vs. SGRY: Which Hospital Stock Looks More Attractive Now?
Apr 22, 2026 05:15 AM · zacks.com
Surgery Partners, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call Details
Apr 17, 2026 11:08 AM · globenewswire.com
Reviewing Progyny (NASDAQ:PGNY) & Surgery Partners (NASDAQ:SGRY)
Apr 12, 2026 10:18 PM · defenseworld.net
SGRY: ADJUSTED EBITDA FELL SHY OF MANAGEMENT'S GUIDED PROJECTIONS -- LEVI & KORSINSKY, LLP INVESTIGATES
Apr 01, 2026 05:00 AM · prnewswire.com
Surgery Partners (NASDAQ:SGRY) Reaches New 52-Week Low – What’s Next?
Mar 28, 2026 10:39 PM · defenseworld.net
Medicus Pharma Business Update Call to Highlight 80% Overall Response Rate (ORR) in Phase 2 SkinJect Study and Agentic AI-enabled Drug Development Plan
Mar 26, 2026 03:30 AM · globenewswire.com